Rambam Healthcare Campus
Rambam Healthcare Campus
Haifa, Israel3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-10-01 | NCT02227251 | |
| Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population | Healthy | Recruiting | Not stated | 2026-08-11 | NCT05837884 | |
| Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders: | Dyskinesias, Neurologic Manifestations, Pain, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, essential tremor, movement disorder, nervous system disorder, neuralgia, neurodegenerative disease, neuromuscular disease, parkinsonian disorder, peripheral nervous system disorder, synucleinopathy | Active, not recruiting | Not stated | 2025-05-02 | NCT03100474 |